That warm, tingling face
after a niacin pill? It’s not a feature. It’s a side effect.

What niacin actually does in the body

Niacin, or Vitamin B3, is the precursor to two coenzymes that show up almost everywhere in human metabolism: NAD+ and NADP+. Together, these two molecules are required by more than 400 enzymatic reactions, most centrally the pathways your cells use to convert food into usable energy. NAD+ status has also become a genuine area of research interest as it relates to cellular aging — a legitimate scientific conversation, though worth separating from the specific, RDA-level role niacin plays in a standard daily multivitamin, which is about covering baseline requirement, not a mega-dose anti-aging intervention.

Niacin vs. niacinamide — the practical difference

Vitamin B3 exists in two commonly supplemented forms: nicotinic acid (niacin) and niacinamide (nicotinamide). Both eventually become the same NAD+ and NADP+ coenzymes once inside the body, so their core metabolic function overlaps. The practical difference that actually matters for most people taking a daily multivitamin comes down to one thing: niacin causes a flush at meaningful doses, and niacinamide does not.

The flush, explained — and why it isn’t the point

The “niacin flush” is real, well-documented, and has nothing mysterious about it: nicotinic acid triggers the release of prostaglandin D2 in the skin, which causes blood vessels to dilate. The result is a temporary warmth, redness, and tingling sensation, usually across the face and chest, sometimes accompanied by itching.

This matters because a persistent bit of supplement folklore treats the flush as reassuring — a visible sign that a pill is doing something. It isn’t. It’s a vasodilation side effect specific to nicotinic acid, and it has no bearing on how well niacinamide, the form actually used in most multivitamins, is being absorbed or used. The absence of a flush from a niacinamide-based supplement is not a sign of a weaker or less effective product — it’s simply a different, non-flushing form doing the same underlying job.

Pellagra and deficiency — the classic story, and the tryptophan detail most people miss

Severe, prolonged niacin deficiency causes pellagra, classically remembered by the “4 D’s”: dermatitis (a distinctive, symmetrical rash on sun-exposed skin), diarrhea, dementia, and death if left untreated. Historically, pellagra epidemics were strongly linked to diets heavily dependent on maize, where niacin is present in a bound, poorly bioavailable form unless the grain is properly processed. In parts of India, a similar risk factor applies to sorghum (jowar), a significant regional staple grain with the same underlying issue.

There’s a genuinely interesting detail worth knowing: the body can synthesize niacin from the amino acid tryptophan, found in protein-rich foods. Roughly 60mg of tryptophan converts to about 1mg of niacin — which is why the RDA is expressed in Niacin Equivalents (NE) rather than plain milligrams, accounting for both direct dietary niacin and what the body manufactures on its own from adequate protein intake.

The B2, B6, and B3 connection — and why TB treatment is relevant here

That tryptophan-to-niacin conversion doesn’t happen on its own — it requires adequate status of two other B vitamins, B2 and B6, as cofactors. This creates a genuinely interesting three-way dependency worth connecting to what we’ve already covered: our Vitamin B2 page covers riboflavin’s role activating folate and B6, and our Vitamin B6 page covers how isoniazid, the first-line tuberculosis drug, depletes B6. That same isoniazid connection extends directly to niacin.

Who’s most at risk of niacin deficiency

What to actually take away from this